E-Home Household Service Holdings Limited — Form 6-K Summary
Business context and reporting period
E-Home Household Service Holdings Limited, a China-based provider of integrated household services, filed this Form 6-K for December 2022. The December 20, 2022 announcement reports a definitive equity transfer agreement to increase the Company’s ownership of Zhongrun (Fujian) Pharmaceutical Co., Ltd., a pharmaceutical and health-products company.
Transaction and key financial terms
- Hong Kong E-Home, a controlled subsidiary, agreed to acquire 4,660,129 Zhongrun shares, representing approximately 20% of Zhongrun’s issued share capital.
- Total consideration is RMB20 million, payable through the issuance of 4,660,129 new E-Home ordinary shares rather than cash.
- The consideration shares represent approximately 45.07% of E-Home’s issued share capital before issuance and approximately 31.07% of the enlarged share capital after issuance.
- Following closing, E-Home expects to hold approximately 75% of Zhongrun, including approximately 55% acquired in the June 14, 2022 transaction.
- Ms. Ling Chen will retain a 25% interest in Zhongrun, will be appointed Chief Operating Officer of Zhongrun, and will cause Hong Kong E-Home to appoint a new executive director.
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics for E-Home or Zhongrun, nor does it quantify the expected financial contribution of the acquisition.
Material changes versus the prior comparable disclosure
- Compared with the June 15, 2022 Form 6-K, the Company entered into a definitive agreement for an additional approximately 20% interest in Zhongrun.
- The transaction would increase E-Home’s ownership and control of Zhongrun to approximately 75% upon closing.
- The acquisition will substantially increase E-Home’s share count and may result in significant dilution to existing shareholders; the filing does not provide the post-transaction number of shares outstanding.
Outlook, management commentary, risks, and unusual items
Management described the transaction as supporting E-Home’s repositioning toward the pharmaceutical and health industry, expansion of a second principal business, and integration of Zhongrun with E-Home’s family-services ecosystem. Zhongrun operates in pharmaceutical distribution, medicine and health-product sales, medical care, health physiotherapy, remote clinics, and online and offline B2B and B2C channels.
The filing states that the transaction remains subject to the terms of the equity transfer agreement and does not specify a closing date or other closing conditions in the announcement. The agreement’s full English translation is furnished as Exhibit 99.1.
Forward-looking statements are subject to risks and uncertainties, including the ability to complete and integrate the acquisition, realize expected benefits, expand Zhongrun’s business, manage the enlarged operations, and achieve anticipated performance. The Company cautions that actual results may differ materially from expectations and refers investors to its SEC filings for additional risk factors.
Important facts for investors to verify
- Whether and when the acquisition closed and whether all stated ownership percentages were achieved.
- The final number of E-Home shares issued, the resulting ownership of Ms. Chen and her nominees, and the effect on existing shareholders.
- The consideration shares’ issuance terms, registration or listing status, and any related-party or governance implications.
- Zhongrun’s historical revenue, profitability, cash flow, assets, liabilities, customer concentration, and regulatory status, which are not provided in this filing.
- The terms of the June 2022 Zhongrun acquisition and the basis for the Company’s stated approximately 75% post-closing ownership.
- Any subsequent SEC filings describing closing conditions, accounting treatment, purchase price allocation, impairment exposure, or integration results.